Dyne Therapeutics
200 hedge funds and large institutions have $2.63B invested in Dyne Therapeutics in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 68 increasing their positions, 63 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
35% less capital invested
Capital invested by funds: $4.03B → $2.63B (-$1.4B)
65% less call options, than puts
Call options by funds: $3.57M | Put options by funds: $10.3M
Holders
200
Holding in Top 10
7
Calls
$3.57M
Puts
$10.3M
Top Buyers
| 1 | +$42.4M | |
| 2 | +$19.4M | |
| 3 | +$16M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$13.3M |
| 5 |
O
OrbiMed
New York
|
+$12.2M |
Top Sellers
| 1 | -$37.7M | |
| 2 | -$30.2M | |
| 3 | -$24.3M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$23.3M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$19.7M |